Ключевые слова:
Parkinson kasalligi, immun tizimi, sitokinlar, mikroglia, T-limfotsitlar, neyroinflammatsiya.Библиографические ссылки
Mahmudov M.A., Yusupov S.M. Parkinson kasalligining klinik xususiyatlari // Tibbiyotda yangi kun. – 2023. – №1. – B. 45–48.
Tansey M.G., Goldberg M.S. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention // Neurobiology of Disease. – 2010. – Vol. 37. – P. 510–518.
Rocha N.P., et al. Neuroinflammation in Parkinson’s disease: role of cytokines // Current Pharmaceutical Design. – 2016. – Vol. 22. – P. 541–5 48.
Qin L., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration // Glia. – 2007. – Vol. 55. – P. 453–462.
Hirsch E.C., Hunot S. Neuroinflammation in Parkinson’s disease: a target for neuroprotection? // The Lancet Neurology. – 2009. – Vol. 8(4). – P. 382–397.
Nagatsu T., Sawada M. Inflammatory process in Parkinson’s disease: role for cytokines // Current Pharmaceutical Design. – 2005. – Vol. 11. – P. 99 9–1016.
Dufek M., et al. Serum inflammatory biomarkers in Parkinson’s disease // Parkinsonism & Related Disorders. – 2009. – Vol. 15. – P. 318–320.
Brochard V., et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease // Journal of Clinical Investigation. – 2009. – Vol. 119 (1). – P. 182–192.
Zhang W., Wang T., Pei Z., et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson’s disease // FASEB Journal. – 2005. – Vol. 19(6). – P. 533–542.
Kannarkat G.T., Boss J.M., Tansey M.G. The role of innate and adaptive immunity in Parkinson’s disease // Journal of Parkinson’s Disease. – 2013. – Vol. 3(4). – P. 493–514.
Al-Dalahmah O., et al. Regional and cellular gene expression changes in human Parkinson’s disease brain // Acta Neuropathologica Communications. – 2020. – Vol. 8. – Article 54.
Lindqvist D., Kaufman E., Brundin L., et al. Non-motor symptoms in Parkinson’s disease – associations with inflammatory cytokines // Brain, Behavior, and Immunity. – 2012. – Vol. 26(6). – P. 930–935.
Moehle M.S., et al. The role of microglia in Parkinson’s disease neuroinflammation // Neurobiology of Disease. – 2012. – Vol. 47. – P. 1–8.
Tan E.K., Chao Y.X., West A., Chan L.L., Poewe W., Jankovic J. Parkinson disease and the immune system – associations, mechanisms and therapeutics // Nature Reviews Neurology. – 2020. – Vol. 16(6). – P. 303–318.
Grozdanov V., Bliederhaeuser C., Ruf W.P., et al. Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients // Acta Neuropathologica. – 2014. – Vol. 128(5). – P. 651–663.
Chen H., O‘Reilly E.J., Schwarzschild M.A., et al. Peripheral inflammatory biomarkers and risk of Parkinson’s disease // American Journal of Epidemiology. – 2008. – Vol. 167(1). – P. 90–95.
Sommer A., Winner B., Prots I. The Trojan horse – neuroinflammatory impact of T cells in neurodegenerative diseases // Molecular Neurodegeneration. – 2017. – Vol. 12. – Article 78.
Cebrián C., Loike J.D., Sulzer D. Neuroinflammation in Parkinson’s disease animal models: a cell stress response or a step-in neurodegeneration? // Current Topics in Behavioral Neurosciences. – 20 14. – Vol. 22. – P. 237–270.
Harms A.S., Cao S., Rowse A.L., et al. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration // Journal of Neuroscience. – 2013. – Vol. 33(23). – P. 9592–9600.
Bentea E., Verbruggen L., Massie A. The immunomodulatory effects of PD medications: a neglected aspect? // Frontiers in Pharmacology. – 20 17. – Vol. 8. – Article 248.
Reale M., et al. Peripheral cytokines profile in Parkinson’s disease // Brain, Behavior, and Immunity. – 2009. – Vol. 23(1). – P. 55–63.
Huang Y., Halliday G.M. Can immune mechanisms be targeted to halt Parkinson’s disease progression? // Current Opinion in Neurology. – 2012. – Vol. 25(3). – P. 254–260.
Su X., Federoff H.J., Maguire-Zeiss K.A. Mutant α-synuclein overexpression mediates early proinflammatory activity // Neurotoxicity Research. – 2009. – Vol. 16(3). – P. 238–254.